ALL Hub

De: Scientific Education Support
Escúchala gratis

  • Resumen

  • The ALL Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in ALL. Our aim is to enhance knowledge in ALL, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.

    Hosted on Acast. See acast.com/privacy for more information.
    Scientific Education Support
    Más Menos
Más Menos
Episodios
  • Consolidation therapy in newly diagnosed adult patients with Ph-negative B-cell ALL

    Consolidation therapy in newly diagnosed adult patients with Ph-negative B-cell ALL
    Mar 3 2025
    During the ALL Hub steering committee meeting, Mark Litzow chaired a discussion on consolidation therapy in newly diagnosed adult patients with Philadelphia chromosome-negative B-cell ALL.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    26 m
  • Optimizing treatment for adults with R/R Ph-negative B-cell ALL

    Optimizing treatment for adults with R/R Ph-negative B-cell ALL
    Mar 3 2025
    During the ALL Hub Steering Committee meeting, Wendy Stock chaired a discussion on optimizing treatment for adults with relapsed/refractory Philadelphia chromosome-negative B-cell ALL.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    33 m
  • Key considerations when preparing patients with ALL for CAR T-cell therapy

    Key considerations when preparing patients with ALL for CAR T-cell therapy
    Jul 12 2024
    During the ALL Hub Steering Committee meeting, André Baruchel chaired a discussion on “What are the key considerations when preparing patients with ALL for CAR T-cell therapy ?”, featuring Andrea Biondi, Anita Rijneveld, and José María Ribera.


    The discussion topics included:

    • Key considerations when selecting patients: stable disease, degree of antigen expression, burden of bone marrow disease, and number of circulating tumor blasts
    • Bridging therapy and lymphodepletion considerations
    • The impact of prior exposure to blinatumomab and inotuzumab on CAR T-cell outcomes
    • Indications for the use of tisagenlecleucel in pediatric ALL
    • Indications for the use of brexucabtagene autoleucel in adult ALL

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    26 m
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre ALL Hub

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles